Diabetic eye disease
Showing 9976 - 10000 of >10,000
Diabetic Cardiomyopathies Trial in Nice (Physiomance acide lipoïque gold, Placebo - Physiomance acide lipoïque gold)
Recruiting
- Diabetic Cardiomyopathies
- Physiomance acide lipoïque gold
- Placebo - Physiomance acide lipoïque gold
-
Nice, FranceNice Hospital
Dec 7, 2020
NASH - Nonalcoholic Steatohepatitis Trial in Brussels (DMR)
Completed
- NASH - Nonalcoholic Steatohepatitis
- DMR
-
Brussels, BelgiumErasme Hospital
Feb 24, 2021
Long Term Cardiovascular Risk Prediction in Emergency Department
Completed
- Cardiovascular Diseases
- +2 more
- Semi-structured interview
-
Manchester, United KingdomManchester Royal Infirmary
Jun 29, 2022
Obesity, Nonalcoholic Fatty Liver Disease, Cardiovascular Disease Trial in Jacksonville (N-acetyl cysteine 600 mg once/day,
Completed
- Obesity
- +2 more
- N-acetyl cysteine 600 mg once/day
- +2 more
-
Jacksonville, FloridaNemours Children's Clinic/Alfred I duPont Hospital
Oct 13, 2022
Bladder Cancer Trial in Fairway, Kansas City (Ascorbic Acid)
Active, not recruiting
- Bladder Cancer
- Ascorbic Acid
-
Fairway, Kansas
- +2 more
Sep 21, 2022
Intrahepatic Cholangiocarcinoma Trial in Padova (Liver transplantation)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Liver transplantation
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 25, 2023
Personalised Disease Monitoring in Metastatic Breast Cancer
Recruiting
- Breast Cancer Metastatic
- Estrogen Receptor-positive Breast Cancer
-
Gothenburg, Sweden
- +6 more
Dec 7, 2022
Gastric Cancer Trial (Disitamab Vedotin Combined With Sintilimab)
Not yet recruiting
- Gastric Cancer
- Disitamab Vedotin Combined With Sintilimab
- (no location specified)
Jan 31, 2023
Inflammation Trial in Buffalo (Pioglitazone 15mg, pioglitazone 30mg, )
Completed
- Inflammation
- Pioglitazone 15mg
- +2 more
-
Buffalo, New YorkMillard Fillmore gates Hospital
Jan 12, 2022
Psoriatic Arthritis Trial in Worldwide (Apremilast 20mg, Apremilast 30mg, Placebo)
Completed
- Psoriatic Arthritis
- Apremilast 20mg
- +2 more
-
Phoenix, Arizona
- +117 more
May 26, 2022
Healthy Controls, Heavy Drinkers, and Alcoholic Hepatitis
Recruiting
- Alcoholic Hepatitis
- Blood Draw
-
Cleveland, OhioCleveland Clinic Foundation
Oct 19, 2022
Caregiver Burden, Alzheimer Trial in Miami Beach (Brain CareNotes, Dementia Guide Expert)
Recruiting
- Caregiver Burden
- Alzheimer Disease
- Brain CareNotes
- Dementia Guide Expert
-
Miami Beach, FloridaMount Sinai Medical Center
Oct 19, 2023
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Coronary Artery Disease Trial in United States (Colchicine, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine
- Placebo
-
Long Beach, California
- +4 more
Nov 15, 2022
Coronary Artery Disease, Diabetes, Metabolic Syndrome Trial in Storrs (Consume 2 eggs with spinach per day, Egg Subsitute with
Completed
- Coronary Artery Disease
- +2 more
- Consume 2 eggs with spinach per day
- Egg Subsitute with spinach per day
-
Storrs, ConnecticutDepartment of Nutritional Sciences
Nov 1, 2022
Is Our Microbiome a Predictor of Cardiac Risk
Recruiting
- Coronary Artery Disease
-
Rochester, MinnesotaMayo Clinic
Oct 20, 2022
Biomarkers of Cognitive Impairment in Blood Cells
Recruiting
- Mild Cognitive Impairment Due to Alzheimer's Disease
- Dementia Due to Alzheimer's Disease (Disorder)
- No intervention will be performed.
-
Palma, Mallorca, Balearic Islands, SpainUniversity of the Balearic Islands
Oct 19, 2022
COPD Trial in Guangzhou (Tiotropium Bromide Combined With Odaterol)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Tiotropium Bromide Combined With Odaterol
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory Diseases
Oct 19, 2022
NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
- Docetaxel
-
Beijing, China
- +37 more
Jan 9, 2023
Follicular Lymphoma Trial in France (Rituximab IV, Rituximab SC)
Completed
- Follicular Lymphoma
- Rituximab IV
- Rituximab SC
-
Aix En Provence, France
- +49 more
Jan 9, 2023
COVID-19, Infections, Morality Trial in Fuzhou (Medical observation, Supportive treatment (BSC), Intensive care management)
Recruiting
- COVID-19
- +3 more
- Medical observation
- +2 more
-
Fuzhou, Fujian, ChinaThe 900th Hospital of the Joint Logistic Support Force, PLA
Jan 7, 2023
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)
Active, not recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- Isatuximab
- +3 more
-
Poitiers, FranceCHU Poitiers
Jan 9, 2023
Chorea Associated With Huntington Disease Trial in Australia, Canada, United States (SD-809)
Completed
- Chorea Associated With Huntington Disease
-
Birmingham, Alabama
- +37 more
Nov 5, 2021
Obesity, Insulin Resistance Trial in Saint Louis (Metabolically abnormal obese - Mediterranean diet, Metabolically abnormal
Recruiting
- Obesity
- Insulin Resistance
- Metabolically abnormal obese - Mediterranean diet
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 12, 2022